To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of mental health medication on the motor function of adults living with cerebral palsy.
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential effect of medication used to manage motor function on the mental health of adults living with cerebral palsy.
No specific assessments have been made. The National Institute for Health and Care Excellence guideline ‘Cerebral palsy in adults’, published in January 2019, sets out best practice guidance for clinicians in considering the effects of medication for adults living with cerebral palsy. It recommends that clinicians should consider the specific factors that might affect identifying, assessing and managing mental health problems and emotional difficulties in people with cerebral palsy. These include the adverse effects of medicines, including the effects of medicines used for managing mental health problems on motor function, or those used for managing motor function on mental health. This guidance is available at the following link: